The majority of SARS-CoV-2 vaccines in use or advanced development are based on the viral spike protein (S) as their immunogen. S is present on virions as prefusion trimers in which the receptor binding domain (RBD) is stochastically open…
From Mailer-Daemon Thu Aug 03 04:31:46 2006 Received: from mailman by lists.gnu.org with archive (Exim 4.43) id 1G8YcM-0002dO-1t for [email protected]; Thu, 03 Aug 2006 04:31:46 -0400 Received: from mailman by lists.gnu.org with…